A needs assessment survey to inform a general practitioner in oncology (GPO) training program in Nepal.

Authors

Bishal Gyawali

Bishal Gyawali

Brigham and Women's Hospital, Boston, MA

Bishal Gyawali , Laura M. Carson , Niresh Thapa , Colleen Savage , Mangal Rawal , Scott R. Berry , Bishesh Sharma Poudyal

Organizations

Brigham and Women's Hospital, Boston, MA, Queen's University, Kingston, ON, Canada, Karnali Academy of Health Sciences, Jumlā, Nepal, Karnali Academy of Health Sciences, Jumla, Nepal, Civil Service Hospital of Nepal, Kathmandu, Nepal

Research Funding

Other

Background: Nepal is a low-income country with a population of over 30 million that faces a significant burden of cancer, with approximately 60,000 patients receiving a cancer diagnosis per year. However, a lack of cancer care providers is recognized as a major barrier to cancer care in Nepal. To address this gap, a national GPO training program may be an effective task-shifting strategy to increase the oncology workforce. A needs assessment survey was conducted to determine baseline oncology training for Nepalese General Practitioners (GPs) and the feasibility and desirability of establishing a GPO training program in Nepal. Methods: A survey was distributed to 171 GPs in Nepal. The survey was distributed via the REDCap electronic database, a secure-web-based software platform based at Queen’s University in Kingston, Ontario, Canada. Reminders were sent out via social media accounts. The survey results were recorded anonymously from February to July 2021. Results: Data was collected from 71 GPs in Nepal. Data revealed significant gaps in oncology training, with only 6% of respondents reporting undergoing a mandatory oncology rotation during their training, and 15% indicating their training adequately prepared them to care for patients with cancer. Although respondents reported seeing an average of 1-5 cancer patients per day, only 9% reported providing chemotherapy treatment, and 36% indicated regular provision of follow-up cancer care. Only 1 in 5 general practitioners reported having radiation oncology services available at their institution or an institution within the same zone. 96% of GPs surveyed agreed that there is a need for a GPO program, and 71% reported they would be very interested in participating in this type of training. A majority of respondents indicated a preference for self-directed and small-group learning as the preferred modes of content delivery in a GPO training program. Conclusions: Our findings indicate a need and high level of desirability for a national GPO training program in Nepal. Further, the needs assessment provides insight into practitioner perspectives on information needs and content delivery. This data will be used to guide future curriculum development for the Nepal GPO program.

Demographics and needs assessment of survey respondents.

Variable
Frequency
Percentage
Total
71
100.0
Gender


 Man
62
87.3
 Woman
9
12.7
 Others
0
0.0
Age


 < 25
0
0.0
 25-34
19
26.8
 35-44
44
62.0
 45-54
6
8.5
 55-64
2
2.8
 ≥ 65
0
0.0
Years in practice


 1-5
40
56.3
 6-10
20
28.2
 11-15
4
5.6
 16-20
2
2.8
 >20
5
7
Location of current practice


Metropolitan city
33
46.5
Sub-metropolitan city
5
7
Municipality
31
43.7
Village Development Committee (VDC)
2
2.8
Perceived need for a GPO training program in Nepal?


Yes
68
95.8
No
1
1.4
Unsure
2
2.8
Willingness to participate in a GPO training program in Nepal if available


Very interested
50
71.4
Somewhat interested
16
22.9
Neutral
2
2.9
Somewhat not interested
0
0.0
Not interested
2
2.9

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Professional Development and Education Advances

Track

Medical Education and Professional Development

Sub Track

Education Research

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 11024)

DOI

10.1200/JCO.2022.40.16_suppl.11024

Abstract #

11024

Poster Bd #

215

Abstract Disclosures